Some treatments called biologics can help people with severe asthma and other allergic diseases like skin issues and food allergies.
Dupilumab has been shown to work well for skin problems and has been approved, while Omalizumab helps with allergies but isn't approved for that use yet.
There are promising ideas about combining biologic therapy with other treatments for allergies, but more research is needed to confirm if they really work.
The study investigates the rising incidence of cefazolin allergy in patients who receive antibiotic prophylaxis prior to elective surgery.
It employs the OpenBabel chemoinformatics toolbox to identify drugs structurally similar to cefazolin, focusing on a cohort of patients with confirmed cefazolin allergies.
Findings reveal that 78% of allergic patients had prior exposure to cefazolin, suggesting that increased usage of this antibiotic since 2010 may be linked to the rise in allergy cases.